AFSM - ETF AI Analysis
Top Page
First Trust Active Factor Small Cap ETF (AFSM)
AFSM vs. SPDR S&P 500 ETF (SPY)
- AUM
- 129.56M
- Region
- North America
- Expense Ratio
- 0.75%
- Beta
- 0.94
- Issuer
- First Trust
- Inception Date
- Dec 03, 2019
- Dividend Yield
- 0.51%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
AFSM Summary
AFSM, the First Trust Active Factor Small Cap ETF, focuses on smaller U.S. companies and is actively managed rather than tracking a fixed index. It spreads investments across many sectors like technology, health care, and financials, aiming to find higher-quality small firms with good growth potential. Examples of companies it holds include Par Pacific Holdings and Matson. Someone might invest in AFSM to diversify beyond large, well-known stocks and tap into the long-term growth potential of smaller, more innovative businesses. A key risk is that small-cap stocks can be more volatile, so the ETF’s value can move up and down sharply with the market.
How much will it cost me?
This ETF has an expense ratio of 0.75%, which means you’ll pay about $7.50 per year for every $1,000 invested. That’s higher than the average ETF because it’s actively managed, with professionals selecting and adjusting small-cap stocks rather than simply tracking an index.
What would affect this ETF?
AFSM could benefit if the U.S. economy grows steadily, supporting small, innovative companies in technology, health care, and financials, and if its active strategy successfully picks strong performers among holdings like Par Pacific, Abercrombie & Fitch, and various health care and energy names. On the downside, rising interest rates, economic slowdowns, or tighter regulations on sectors such as financials, energy, or health care could hurt small-cap stocks more than larger companies and increase volatility for this U.S.-focused fund.
AFSM Top 10 Holdings
AFSM is leaning into U.S. small-cap growth stories, with health care and pharmaceuticals like Eton and Kiniksa acting as key engines after a strong run, even if their momentum has turned a bit mixed lately. Shipping names such as Matson and Teekay Tankers add a steady, cash-flow-driven ballast, while consumer player Abercrombie & Fitch, despite earlier strength, is now losing some steam and weighing on short-term results. Overall, the fund is diversified across sectors but has a clear tilt toward small, innovative U.S. health care and energy names driving the narrative.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 PARR | Par Pacific Holdings | 1.13% | $1.46M | $4.24B | 117.41% | 67Neutral |
 NHC | National Healthcare | 1.04% | $1.34M | $3.88B | 96.80% | 74Outperform |
 ANF | Abercrombie Fitch | 0.94% | $1.21M | $6.77B | 136.13% | 78Outperform |
 MATX | Matson | 0.89% | $1.15M | $7.10B | 143.48% | 77Outperform |
 PENG | Penguin Solutions | 0.71% | $912.89K | $3.52B | 141.11% | 61Neutral |
 TNK | Teekay Tankers | 0.79% | $1.01M | $3.28B | 68.42% | 68Neutral |
 HRTG | Heritage Insurance Holdings | 0.80% | $1.03M | $1.10B | 61.25% | 72Outperform |
 HALO | Halozyme | 0.77% | $995.32K | $14.17B | 89.36% | 73Outperform |
 KNSA | Kiniksa Pharmaceuticals | 0.77% | $986.93K | $6.22B | 107.69% | 72Outperform |
 TRST | TrustCo Bank | 0.76% | $972.44K | $931.93M | 50.24% | 78Outperform |
AFSM Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For AFSM, the sentiment is Positive. The current price of 39.63 is below the 20-day moving average (MA) of 39.67, below the 50-day MA of 40.02, and above the 200-day MA of 37.40, indicating a neutral trend. The MACD of -0.09 indicates Negative momentum. The RSI at 48.70 is Neutral, neither overbought nor oversold. The STOCH value of 71.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AFSM.
AFSM Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| AFSM | $39.63 | $44.00(11.03% Upside) | $129.56M | 0.75% | 68Neutral |
 SEIS | $31.57 | $40.47(28.20% Upside) | $617.94M | 0.55% | 68Neutral |
 FSCC | $33.78 | $44.66(32.20% Upside) | $442.95M | 0.36% | 63Neutral |
 FSML | $28.96 | $38.20(31.92% Upside) | $151.33M | 0.45% | 64Neutral |
 SCDV | $25.58 | $33.24(29.94% Upside) | $146.43M | 0.70% | 73Outperform |
 SIXS | $57.61 | $66.29(15.06% Upside) | $140.65M | 0.50% | 68Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AFSM | First Trust Active Factor Small Cap ETF | 39.63 | 6.99 | 21.41% | |
| SEIS | SEI Select Small Cap ETF | 31.57 | 3.39 | 12.03% | |
| FSCC | Federated Hermes MDT Small Cap Core ETF | 33.78 | 3.57 | 11.82% | |
| FSML | Franklin Small Cap Enhanced ETF | 28.96 | 3.46 | 13.57% | |
| SCDV | Bahl & Gaynor Small Cap Dividend ETF | 25.58 | 0.47 | 1.89% | |
| SIXS | ETC 6 Meridian Small Cap Equity ETF | 57.61 | 8.82 | 18.08% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.